Novium | Bonaventure Equity Portfolio Company

A pre-clinical stage biopharmaceutical company focused on life changing medicinal cannabis formulations coupled with innovative drug delivery systems.

Established by a compassionate team of entrepreneurs, scientists, pharmacists and physicians, the Novium team has 40-plus years of experience and specializes in developing novel, proprietary compounded therapies derived through extensive pharmacology of cannabinoids.

Placing patients first, Novium offers proprietary and revolutionary functional wellness alternatives that are focused on specific and targeted terpenoid formulations that have a wide range of effects on varying illnesses and symptoms.  Their full product catalog inclusive of extended release tablets were developed to empower individuals in reclaiming their health and to significantly improve the lives of millions of patients through delivery of its medications and put them on a “Path to a Better Life.”